sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
8-Feb-2016 20:49
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1001-1025 out of 1155.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>

Public Release: 17-Jun-2014
BMC Biology
Researchers map genomic differences in yellow fever, malaria mosquitoes
Virginia Tech entomologists have developed a chromosome map for about half of the genome of the mosquito Aedes agypti, the major carrier of dengue fever and yellow fever. With the map, researchers can chart ways to prevent diseases.

Contact: Lindsay Taylor Key
Virginia Tech

Public Release: 17-Jun-2014
Nature Communications
Study reveals conditions linked to deadly bird flu and maps areas at risks
A dangerous strain of avian influenza, H7N9, that's causing severe illness and deaths in China may be inhabiting a small fraction of its potential range and appears at risk of spreading to other suitable areas of India, Bangladesh, Vietnam, Indonesia and the Philippines, according to a new study published today in the journal Nature Communications.

Contact: Michelle Geis
Burness Communications

Public Release: 17-Jun-2014
Human Dimensions of Wildlife
Thieving chimps changing the way African farmers feed their families
Researchers from Trinity College Dublin's School of Geography found that Rwandan farmers have been forced to grow different crops to reduce losses as they pursue non-violent solutions to the 'natural tax' imposed by hungry primates.

Contact: Thomas Deane
Trinity College Dublin

Public Release: 16-Jun-2014
Nature Communications
Study shows chikungunya mutation places several countries at risk of epidemic
For the first time, University of Texas Medical Branch at Galveston researchers were able to predict further adaptations of the chikungunya virus that recently spread from Africa to several continents that will likely result in even more efficient transmission and infection of more people by this virus strain.
National Institutes of Health, Department of Biotechnology of the Indian Government

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 16-Jun-2014
Journal of Thoracic Oncology
Improved diagnostic performance of low-dose computed tomography screening
Investigators of the COSMOS (Continuous Observation of SMOking Subjects) study show good compliance and patient survival outcomes using a 5-year low-dose computed tomography screening protocol in individuals at high-risk of developing lung cancer.

Contact: Rob Mansheim
International Association for the Study of Lung Cancer

Public Release: 16-Jun-2014
Journal of Thoracic Oncology
No long-term anxiety or distress associated with low-dose computed tomography screening
Examination and review of several studies that evaluated patient-centered outcomes for individuals undergoing low-dose computed tomography screening for lung cancer found that screening does not appear to significantly influence overall health-related quality of life or result in long-term changes in anxiety or distress, but that positive results in the short-term, do increase distress levels.

Contact: Rob Mansheim
International Association for the Study of Lung Cancer

Public Release: 15-Jun-2014
Nature Genetics
Exploring a parasitic tunnel boring machine
The whipworm's unusual strategy of burrowing through the intestine of its human host is explored in an in-depth study of the parasite's genome. Researchers' deeper understanding of the worm's genetics has exposed weaknesses, pointing to potential treatments for the hundreds of millions of people infected in developing countries. This genome could also help researchers harness potentially beneficial features of the worm's unique biology.
Wellcome Trust

Contact: Mary Clarke
Wellcome Trust Sanger Institute

Public Release: 15-Jun-2014
Nature Genetics
Parasitic worms of pigs could provide new treatments of human diseases
Lead researcher, Dr. Aaron Jex, Faculty of Veterinary Science, said, 'We know that humans infected with the harmless, 'pig whipworm' can have significantly reduced symptoms linked to autoimmune diseases. And now we have the genetic sequence of the worm, it opens the door to future human drug designs and treatment.'

Contact: Dr. Andi Horvath
University of Melbourne

Public Release: 15-Jun-2014
Health impacts of planetary change, swelling cities: New assignment for UN think tank in Malaysia
Under a new mandate, UN University's Malaysia-based International Institute for Global Health will advance integrative thinking about the health of people and planetary systems. It will advance insight into the health risks of global change -- symptomized by climate change, urbanization, biodiversity loss -- and the co-benefits for health of environmental action and smart urban development. A new study in Uganda, for example, shows under-18s most vulnerable to cholera, typhoid, acute diarrhea, other water-related health risks rising with climate change.

Contact: Terry Collins
United Nations University International Institute for Global Health

Public Release: 13-Jun-2014
Journal of Christian Nursing
Nurses play critical role in responding to global resurgence of pertussis
Pertussis (whooping cough) is on the increase in the United States and around the world --and nurses play an essential role in educating parents and patients about the safety and effectiveness of pertussis vaccination, according to a paper in the July-September issue of Journal of Christian Nursing, official journal of the Nurses Christian Fellowship. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 13-Jun-2014
Nature Communications
Genetic 'barcode' for malaria could help contain outbreaks
A new genetic 'barcode' for malaria parasites has been found which could be used to track and contain the spread of the disease, according to new research led by the London School of Hygiene & Tropical Medicine. By using this simple genetic marker when analyzing blood samples from malaria patients, organizations could quickly and accurately identify the source of outbreaks, and spot the spread of drug-resistant parasites from Asia to Africa.

Contact: Joel Winston
London School of Hygiene & Tropical Medicine

Public Release: 12-Jun-2014
Grant to entomologist will advance research on African malaria mosquito
Bradley White, an entomologist at the University of California, Riverside, has received a five-year grant exceeding $1.8 million from the National Institute of Allergy and Infectious Diseases. The grant will allow his lab to produce fine-scale recombination rate maps for the African malaria mosquito, Anopheles gambiae. At 31, White is one of the youngest NIH R01 principal investigators in the country (well less than 1 percent of NIH principal investigators are 31 or younger).
NIH/National Institute of Allergy and Infectious Diseases

Contact: Iqbal Pittalwala
University of California - Riverside

Public Release: 10-Jun-2014
Proceedings of the National Academy of Sciences
LSTM researchers identify the complex mechanisms controlling changes in snake venom
Specialist researchers from LSTM have identified the diverse mechanisms by which variations in venom occur in related snake species and the significant differences in venom pathology that occur as a consequence.

Contact: Clare Bebb
Liverpool School of Tropical Medicine

Public Release: 10-Jun-2014
Nature Communications
Scientists wipe out malaria-carrying mosquitoes in the lab by creating male-only offspring
Scientists have modified mosquitoes to produce sperm that will only create males, pioneering a fresh approach to eradicating malaria.
National Institutes of Health

Contact: Gail Wilson
Imperial College London

Public Release: 10-Jun-2014
Journal of Applied Physics
Malaria: Blood cells behaving badly
New insight into how malaria parasites perturb flow, turning infected cells into sticky capillary cloggers, may lead to new and better treatments.

Contact: Jason Bardi
American Institute of Physics

Public Release: 10-Jun-2014
PLOS Medicine
Refugees and internally displaced persons should have equitable access to HIV treatment
'Given recent evidence and the moral, legal, and public health arguments, refugees and internally displaced persons situated in stable settings should have equitable access to HIV treatment and supportive services,' argue experts from the London School of Hygiene & Tropical Medicine and the United Nations High Commissioner for Refugees, writing in this week's PLOS Medicine.
United Nations High Commissioner for Refugees

Contact: Maya Sandler

Public Release: 6-Jun-2014
Nature Communications
Toward a better drug against malaria
A research team led by Prof. Dr. Carola Hunte of the University of Freiburg, Germany, has succeeded in describing how the antimalarial drug atovaquone binds to its target protein. The scientists used x-ray crystallography to determine the three-dimensional structure of the protein with the active substance bound. The drug combination atovaquone-proguanil (Malarone®) is a medication used worldwide for the prevention and treatment of malaria.

Contact: Dr. Carola Hunte
University of Freiburg

Public Release: 6-Jun-2014
PLOS Neglected Tropical Diseases
Deadly diseases overlooked for too long, scientists say
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
European Commission

Contact: Corin Campbell
University of Edinburgh

Public Release: 6-Jun-2014
Nature Communications
Infection in malaria-transmitting mosquito discovered
Researchers have found the first evidence of an intercellular bacterial infection in natural populations of two species of Anopheles mosquitoes, the major vectors of malaria in Africa.
European Research Council

Contact: Todd Datz
Harvard T.H. Chan School of Public Health

Public Release: 5-Jun-2014
UH chemist's work could impact disease management, treatments
A University of Houston chemist hopes his work will one day impact the treatment of such diseases as cancer and malaria by better understanding how molecules react and how atoms come together to form bonds. Jeremy May, an assistant professor of chemistry at UH, received a five-year, $600,000 National Science Foundation CAREER Award to develop synthetic strategies to increase the efficiency and yields of chemical reactions.
National Science Foundation

Contact: Lisa Merkl
University of Houston

Public Release: 4-Jun-2014
Proceedings of the National Academy of Sciences
Hemorrhagic fevers can be caused by body's antiviral interferon response
Virologists and immunologists at The Scripps Research Institute have found a major clue to the mystery of 'hemorrhagic fever' syndromes. The team showed that Interferon Type I immune proteins are key drivers of a viral syndrome in mice that closely mimics human hemorrhagic fevers.
National Institutes of Health

Contact: Mika Ono
Scripps Research Institute

Public Release: 4-Jun-2014
Shared mission of health equity joins NYU GIPH and HealthRight International
A unique collaboration between New York University's Global Institute of Public Health (NYU GIPH) and the global health and human rights organization HealthRight International, Inc. was announced today by Robert Berne, New York University executive vice president for health, Dr. Cheryl Healton, dean of Global Public Health and director of NYU GIPH, and Dr. Peter Navario, HealthRight executive director. NYU GIPH and HealthRight will collaborate on global health programming, research, curricula, work-study placements, and internships.

Contact: Robert Polner
New York University

Public Release: 3-Jun-2014
Global health grant from the Bill & Melinda Gates Foundation awarded to the University of Surrey
The University of Surrey announced today that it has been awarded a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. With the grant, Professor Johnjoe McFadden will aim to revolutionize the control of tuberculosis by modifying the vaccine and designing a new test for the human form of the disease.
Bill & Melinda Gates Foundation

Contact: Peter La
University of Surrey

Public Release: 3-Jun-2014
Liver cancer vaccine effective in mice
Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
NIH/National Cancer Institute

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 30-May-2014
UTHealth's Anil Kulkarni awarded Fulbright Scholarship
Anil Kulkarni, MSc, Ph.D., professor in the Department of Surgery at The University of Texas Health Science Center at Houston Medical School, was awarded a highly competitive Fulbright-Nehru Scholarship Award for Academic and Professional Experience to travel to India this fall to teach immunonutrition and functional foods in the global health era.
Fulbright-Nehru Scholarship Award for Academic and Professional Experience

Contact: Robert Cahill
University of Texas Health Science Center at Houston

Showing releases 1001-1025 out of 1155.

<< < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>